Allspring Global Investments
FMTX

Allspring Global Investments’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Allspring Global Investments’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,313
Closed -$604K – 2985
2022
Q3 		$604K Sell
30,313
-3,318
-10% -$43.8K ﹤0.01% 1542
2022
Q2 		$231K Buy
33,631
+20,193
+150% +$142K ﹤0.01% 1772
2022
Q1 		$124K Buy
13,438
+144
+1% +$1.53K ﹤0.01% 2706
2021
Q4 		$189K Buy
+13,294
New +$230K ﹤0.01% 2644

Allspring Global Investments's FMTX Position: Q4 2022 in Review

Allspring Global Investments sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 30,313 shares — an estimated $604K sold.

Allspring Global Investments first reported a position in FMTX in Q4 2021 and held it in 4 quarters. The position peaked at $604K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Allspring Global Investments reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Allspring Global Investments sold 30,313 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $604K.
  • Allspring Global Investments first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $604K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.